Lyell Immunopharma Payables and Accrued Expenses (Quarterly) Trends

Lyell Immunopharma, Inc. (LYEL)

25.26 -0.58 (-2.24%) USD | NASDAQ | Jan 23, 16:00

25.07 -0.19 (-0.75%) Pre-Market: 20:00

View Payables and Accrued Expenses (Quarterly) for LYEL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Payables and Accrued Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Payables and Accrued Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Payables and Accrued Expenses (Quarterly) Benchmarks

Start Trial

Insmed, Inc.	Upgrade
Nektar Therapeutics	Upgrade
GT Biopharma, Inc.	Upgrade
Ionis Pharmaceuticals, Inc.	Upgrade
Regeneron Pharmaceuticals, Inc.	Upgrade